GRM1 and Arthritis: The data suggest that removal of the mGluR1-mediated blockade of inhibitory transmission with an mGluR1 antagonist restores inhibitory control of excitatory synaptic transmission as is evident from the facilitatory effect of a GABAA-receptor antagonist that was lost in the arthritis pain model.